Boston-based digital therapeutics company Akili Interactive announced Wednesday that it is restructuring its business, including cutting 40% of its staff.
The company, which currently offers a prescription-based video game treatment to improve attention in children with ADHD, plans to shift to a non-prescription business model. That includes seeking regulatory approval for an over-the-counter label for its products.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,